How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014

BACKGROUND: Malaysia’s public healthcare sector provides a greater volume of medicines at lower overall cost compared to the private sector, indicating its importance in providing access to medicines for Malaysians. However, the Ministry of Health (MOH) has concerns about the continuous increase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamzah, NM, Perera, P. N., Rannan-Eliya, R. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275478/
https://www.ncbi.nlm.nih.gov/pubmed/32503539
http://dx.doi.org/10.1186/s12913-020-05362-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275478/
https://www.ncbi.nlm.nih.gov/pubmed/32503539
http://dx.doi.org/10.1186/s12913-020-05362-8

Ejemplares similares